Navigation
Company
Our Science
mTOR Pathway
TSC1
&
TSC2
nab
Technology Platform
Publications and Abstracts
Our Medicine
Our Medicine
Advanced Malignant PEComa
Pipeline
Patients
Overview
Patient Advocacy
Clinical Trials
Contact Us
General Contact
For Healthcare Professionals
Careers
Archive: March 31, 2019
Home
2019
March
31
31
Mar
2019
Patients With Severe Pulmonary Arterial Hypertension Treated With ABI-009,
nab
-Sirolimus, an mTOR Inhibitor: Interim Results From a Phase 1 Clinical Trial
0
0
March 31, 2019
March 31, 2019